Insulin pump therapy: impact on the lives of children/young people with diabetes mellitus and their parents

Background Advances in medical technology and research documenting clinical effectiveness have led to the increased use of insulin pumps worldwide. However, their use by children in the UK is relatively limited and there is little evidence regarding their impact on patients’ lives. Objective This study aimed to examine the impact of switching from multiple daily injections to insulin pumps on the glycaemic control and daily lives of children/young people and their families. Setting University College London Hospital, London. Method Face-to-face semi-structured interviews were conducted with children/young people with type 1 diabetes mellitus (5–17 years; N = 34) and their parents (N = 38), receiving insulin pump therapy and attending paediatric diabetes outpatients clinics at a major university teaching hospital in London. Glycated haemoglobin A1c values from 6 months prior to, and after pump therapy were obtained. Qualitative and quantitative approaches were undertaken for data analysis. Main outcome measure Glycated haemoglobin A1c and the impact of the use of insulin pumps on the children and their families. Results The majority of parents (N = 32) and the children/young people (N = 30) reported that glycaemic control was easier to maintain within the target range with pumps compared to injections. This was supported by glycated haemoglobin A1c measures. Participants generally found the devices easy to use and more acceptable than injections. However, parents and children/young people reported many challenges in the early stages of pump therapy (e.g. 7 children/young had worse control at 6 months after starting CSII). Parents and children/young people reported an overall increase in lifestyle flexibility and an improved ability to participate in home, school and social activities whilst maintaining glycaemic control. Conclusion Administration of insulin via pumps rather than injections was generally preferred. Participants reported most difficulty at the commencement of use. Pump therapy conferred benefits in terms of glycaemic control, general well-being, enabling young people to be more in control of their condition and live more normal lives, as reported by most participants. These are important goals of health policy for children/young people with long-term conditions in the UK.

[1]  K. G. Low,et al.  Insulin pump use in young adolescents with type 1 diabetes: a descriptive study , 2005, Pediatric diabetes.

[2]  J. Merrick,et al.  National Service Framework for Children, Young People and Maternity Services: Key Issues for Primary Care , 2005 .

[3]  E. Carter,et al.  Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections , 2012 .

[4]  K. Barnard,et al.  Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[5]  E. Guba,et al.  Lincoln, Yvonna, and Egon Guba, "Postpositivism and the Naturalist Paradigm," pp. 14-46 in Yvonna Lincoln and Egon Guba, Naturalistic Inquiry . Beverly Hills, CA: Sage, 1985.* , 1985 .

[6]  H. Szajewska,et al.  Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta‐analysis of randomized control trials , 2009, Pediatric diabetes.

[7]  F. Campbell Review: The pros and cons of continuous subcutaneous insulin infusion (CSII) therapy in the paediatric population and practical considerations when choosing and initiating CSII in children: , 2008 .

[8]  H. Chase,et al.  Life with continuous subcutaneous insulin infusion (CSII) therapy: child and parental perspectives and predictors of metabolic control , 2001, Pediatric diabetes.

[9]  K. Knafl,et al.  Parents' reflections on managing their children's diabetes with insulin pumps. , 2004, Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.

[10]  Stephanie R. Johnson,et al.  Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case–control study , 2013, Diabetologia.

[11]  B. Smide,et al.  Continuous subcutaneous insulin infusion in young girls : a two-year follow-up study , 2007 .

[12]  R. Hanås,et al.  Insulin pumps in pediatric routine care improve long‐term metabolic control without increasing the risk of hypoglycemia , 2006, Pediatric diabetes.

[13]  W. Tamborlane,et al.  Persistence of Benefits of Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes: A Follow-up Report , 2004, Pediatrics.

[14]  N. Jospe,et al.  Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective , 2005, Pediatric diabetes.

[15]  S. Keady,et al.  Insulin pumps: from inception to the present and toward the future , 2010, Journal of clinical pharmacy and therapeutics.

[16]  E. Northam,et al.  Behaviour and metabolic control in children with Type 1 diabetes mellitus on insulin pump therapy: 2‐year follow‐up , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[17]  K. Barnard,et al.  Quality of life and impact of continuous subcutaneous insulin infusion for children and their parents , 2008 .

[18]  N. Sulli,et al.  Long‐term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4‐year follow‐up , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[19]  E. Cummins,et al.  Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. , 2010, Health technology assessment.

[20]  C. Messina,et al.  Long-term Efficacy of Insulin Pump Therapy in Children with Type 1 Diabetes Mellitus , 2012, Journal of clinical research in pediatric endocrinology.

[21]  V. Wilson Experiences of parents of young people with diabetes using insulin pump therapy. , 2008, Paediatric nursing.

[22]  S. Shalitin,et al.  Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[23]  L. Meneghini,et al.  Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections. , 2010, Diabetes technology & therapeutics.

[24]  N. Sulli,et al.  Continuous Subcutaneous Insulin Infusion in Children and Adolescents with Diabetes Mellitus: Decreased HbA1c with Low Risk of Hypoglycemia , 2003, Journal of pediatric endocrinology & metabolism : JPEM.